Table 1 Demographics, hepatitis C genotype, and non-invasive fibrosis assessment among Georgian prisoners with chronic hepatitis C infection, December 2013–April 2015
Among prisoners receiving a full diagnostic evaluation | % | |
|---|---|---|
N | 880 | |
Median age (years) | 40 (Range: 18–71) | |
Male (years) | 40 (Range: 18–71) | |
Female (years) | 43 (Range: 25–54) | |
Sex | ||
Male | 858 | 97.5% |
Female | 22 | 2.5% |
HCV Genotype | ||
1 | 200 | 22.7% |
2 | 253 | 28.8% |
3 | 420 | 47.7% |
Mixed 1 & 2 | 5 | 0.6% |
Mixed 1 & 3 | 1 | 0.1% |
6 | 1 | 0.1% |
Non-Invasive Fibrosis Staging | ||
6.5 kPa – < 8.0 kPa (Metavir F2) | 406 | 46.1% |
8.0 kPa – < 10 kPa (Metavir F2-F3) | 192 | 21.8% |
10 kPa – < 12.5 kPa (Metavir F3) | 127 | 14.4% |
12.5 kPa – < 14 kPa (Metavir F3-F4) | 23 | 2.6% |
≥ 14 kPa (Metavir F4) | 132 | 15.0% |
FIB-4 | ||
< 1.45 | 573 | 65.1% |
1.45–3.25 | 255 | 29.0% |
> 3.25 | 52 | 5.9% |
APRI | ||
< 1.0 | 651 | 74.0% |
1.0–2.0 | 167 | 19.0% |
> 2.0 | 62 | 7.0% |